Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases


Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *